...
search icon
cycc-img

Cyclacel Pharmaceuticals Inc, Common Stock

CYCC

NAQ

$1.45

-$0.01

(-0.68%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$44.54M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0.5069
Volume info-icon
This is the total number of shares traded during the most recent trading day.
146.27K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0.53
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.43 L
$47.71 H
$1.45

About Cyclacel Pharmaceuticals Inc, Common Stock

Cyclacel Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer medicines based on cell cycle, epigenetics, and mitosis biology in the United States and the United Kingdom. Its lead product, Plogosertib or plogo, is a PLK1 inhibitor, in solid tumors and hematological malignancies, which is in Phase 1/2 clinical trial. The company was founded in 1996 and is headquartered in Kuala Lumpur, Malaysia. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameCYCCSectorS&P500
1-Week Return-27.5%-1.91%-1.87%
1-Month Return-60.63%-3.82%8.93%
3-Month Return-72.83%-11.56%-2.39%
6-Month Return-73.66%-10.21%-2.41%
1-Year Return-95.58%-9.91%10.88%
3-Year Return-99.55%-0.28%46.93%
5-Year Return-99.9%31.29%94.89%
10-Year Return-100%75.9%177.5%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue5.88K-373.00K420.00K43.00K[{"date":"2020-12-31","value":1.4,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":88.81,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":10.24,"profit":true}]
Cost of Revenue20.00K43.00K32.00K32.00K6.00K[{"date":"2020-12-31","value":46.51,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":74.42,"profit":true},{"date":"2023-12-31","value":74.42,"profit":true},{"date":"2024-12-31","value":13.95,"profit":true}]
Gross Profit(20.00K)(43.00K)(32.00K)420.00K37.00K[{"date":"2020-12-31","value":-4.76,"profit":false},{"date":"2021-12-31","value":-10.24,"profit":false},{"date":"2022-12-31","value":-7.62,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":8.81,"profit":true}]
Gross Margin(340.31%)-(8.58%)100.00%86.05%[{"date":"2020-12-31","value":-340.31,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-8.58,"profit":false},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":86.05,"profit":true}]
Operating Expenses10.64M22.94M27.66M25.87M12.05M[{"date":"2020-12-31","value":38.46,"profit":true},{"date":"2021-12-31","value":82.94,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":93.55,"profit":true},{"date":"2024-12-31","value":43.56,"profit":true}]
Operating Income(10.64M)(22.94M)(27.66M)(25.45M)(12.00M)[{"date":"2020-12-31","value":-1063600000,"profit":false},{"date":"2021-12-31","value":-2293800000,"profit":false},{"date":"2022-12-31","value":-2765600000,"profit":false},{"date":"2023-12-31","value":-2545300000,"profit":false},{"date":"2024-12-31","value":-1200400000,"profit":false}]
Total Non-Operating Income/Expense997.00K220.00K1.95M267.00K22.00K[{"date":"2020-12-31","value":51.1,"profit":true},{"date":"2021-12-31","value":11.28,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":13.69,"profit":true},{"date":"2024-12-31","value":1.13,"profit":true}]
Pre-Tax Income(9.68M)(22.73M)(25.91M)(25.55M)(11.99M)[{"date":"2020-12-31","value":-968100000,"profit":false},{"date":"2021-12-31","value":-2273400000,"profit":false},{"date":"2022-12-31","value":-2591500000,"profit":false},{"date":"2023-12-31","value":-2555100000,"profit":false},{"date":"2024-12-31","value":-1199400000,"profit":false}]
Income Taxes(1.24M)(3.85M)(4.72M)(3.00M)(782.00K)[{"date":"2020-12-31","value":-123600000,"profit":false},{"date":"2021-12-31","value":-384700000,"profit":false},{"date":"2022-12-31","value":-471700000,"profit":false},{"date":"2023-12-31","value":-299600000,"profit":false},{"date":"2024-12-31","value":-78200000,"profit":false}]
Income After Taxes(8.45M)(18.89M)(21.20M)(22.55M)(11.21M)[{"date":"2020-12-31","value":-844500000,"profit":false},{"date":"2021-12-31","value":-1888700000,"profit":false},{"date":"2022-12-31","value":-2119800000,"profit":false},{"date":"2023-12-31","value":-2255500000,"profit":false},{"date":"2024-12-31","value":-1121200000,"profit":false}]
Income From Continuous Operations(8.45M)(18.89M)(21.20M)(24.70M)(11.21M)[{"date":"2020-12-31","value":-844500000,"profit":false},{"date":"2021-12-31","value":-1888700000,"profit":false},{"date":"2022-12-31","value":-2119800000,"profit":false},{"date":"2023-12-31","value":-2470300000,"profit":false},{"date":"2024-12-31","value":-1121200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(8.45M)(18.89M)(21.20M)(22.55M)(11.21M)[{"date":"2020-12-31","value":-844500000,"profit":false},{"date":"2021-12-31","value":-1888700000,"profit":false},{"date":"2022-12-31","value":-2119800000,"profit":false},{"date":"2023-12-31","value":-2255500000,"profit":false},{"date":"2024-12-31","value":-1121200000,"profit":false}]
EPS (Diluted)(3.87)(2.14)(1.90)(7.63)-[{"date":"2020-12-31","value":-387,"profit":false},{"date":"2021-12-31","value":-214,"profit":false},{"date":"2022-12-31","value":-190,"profit":false},{"date":"2023-12-31","value":-763,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

CYCC
Cash Ratio 5.20
Current Ratio 5.60

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

CYCC
ROA (LTM) -160.18%
ROE (LTM) -1950.23%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

CYCC
Debt Ratio Lower is generally better. Negative is bad. 0.18
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.82

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

CYCC
Trailing PE 0.51
Forward PE NM
P/S (TTM) 2322.68
P/B 10.62
Price/FCF NM
EV/R 2076.90
EV/Ebitda 0.02
PEG NM

FAQs

What is Cyclacel Pharmaceuticals Inc share price today?

Cyclacel Pharmaceuticals Inc (CYCC) share price today is $1.45

Can Indians buy Cyclacel Pharmaceuticals Inc shares?

Yes, Indians can buy shares of Cyclacel Pharmaceuticals Inc (CYCC) on Vested. To buy Cyclacel Pharmaceuticals Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CYCC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Cyclacel Pharmaceuticals Inc be purchased?

Yes, you can purchase fractional shares of Cyclacel Pharmaceuticals Inc (CYCC) via the Vested app. You can start investing in Cyclacel Pharmaceuticals Inc (CYCC) with a minimum investment of $1.

How to invest in Cyclacel Pharmaceuticals Inc shares from India?

You can invest in shares of Cyclacel Pharmaceuticals Inc (CYCC) via Vested in three simple steps:

  • Click on Sign Up or Invest in CYCC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Cyclacel Pharmaceuticals Inc shares
What is Cyclacel Pharmaceuticals Inc 52-week high and low stock price?

The 52-week high price of Cyclacel Pharmaceuticals Inc (CYCC) is $47.71. The 52-week low price of Cyclacel Pharmaceuticals Inc (CYCC) is $1.43.

What is Cyclacel Pharmaceuticals Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Cyclacel Pharmaceuticals Inc (CYCC) is 0.5069

What is Cyclacel Pharmaceuticals Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Cyclacel Pharmaceuticals Inc (CYCC) is 10.62

What is the Market Cap of Cyclacel Pharmaceuticals Inc?

The market capitalization of Cyclacel Pharmaceuticals Inc (CYCC) is $44.54M

What is Cyclacel Pharmaceuticals Inc’s stock symbol?

The stock symbol (or ticker) of Cyclacel Pharmaceuticals Inc is CYCC

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top